Claes Wahlestedt, PhD, MD

Pacific Biosciences thesis

Recent press New item found. HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss May 11, 2026 | GLOBE NEWSWIRE PacBio Announces First Quarter 2026 Financial Results May 07, 2026 | GLOBE NEWSWIRE PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing April 21, 2026 | GLOBE NEWSWIRE View all Recent articles The power of one: How assay consolidation and menu expansion reshape sequencing economics May 14, 2026

Sector and stage focus

• general: Los Angeles / Southern California, San Francisco Bay Area, Boston / New England, Diverse Investors, New York City, Investors who invested in diverse founders, Investors who were founders, Investors who invested in female founders
• Seed: Drug Delivery, Pharmaceuticals, Diagnostics, Health & Hospital Services, AI, Digital Health, BioTech, Generative Tech/AI, Consumer Health, Health IT
• Series B: Drug Delivery, Consumer Health, Pharmaceuticals, BioTech, AI, Health IT, Health & Hospital Services, Diagnostics, Digital Health, Generative Tech/AI
• Pre-seed: Drug Delivery, Pharmaceuticals, AI, Diagnostics, Consumer Health, BioTech, Digital Health, Health IT, Health & Hospital Services, Generative Tech/AI
• Series A: Drug Delivery, Pharmaceuticals, BioTech, AI, Health IT, Health & Hospital Services, Diagnostics, Digital Health, Generative Tech/AI, Consumer Health

Is Claes Wahlestedt, PhD, MD a fit for your round?

Upload your pitch deck and see whether Claes Wahlestedt, PhD, MD appears in your top 20 matches.